CIRM Approves New and Updated Funding Programs, Awards $26.5 Million for Clinical Research and Development
On Mar. 27, 2025, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
CIRM Awards Nearly $100 Million to Boost Discovery, Translational, and Clinical Disease Research
On Jan. 30, 2025, the California Institute for Regenerative Medicine (CIRM) announced it has awarded nearly $100 million…
Giant study found untrustworthy trials pollute gold-standard medical reviews
On Dec. 18, 2024, A huge collaboration has confirmed growing concerns that fake or flawed research is polluting…
First new treatment for asthma attacks in 50 years
On Nov. 28, 2024, scientists from King’s College London reported that an injection given during some asthma and…
CIRM Awarded $29.7 Million to Advance rare pediatric disease Clinical Projects
On Nov. 21, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had approved awarding $29.7 million to…
Paxlovid cuts COVID hospitalization, death risk and speeds symptom relief, studies find
On Nov. 11, 2024, findings from two studies have tied use of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) to…
Biotechnology | Diagnostics | Disease | Oncology | Vaccine | Women's Health
Anixa Biosciences and Cleveland Clinic Presented Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine
On Nov. 8, 2024, Anixa Biosciences announced updated positive data from the Phase 1 clinical trial of its…
Mpox vaccine is safe and generates a robust antibody response in adolescents
On Oct. 16, 2024, a National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents…
RedHill Biopharma Secured U.S. Government Funding through BARDA to Advance Opaganib for Ebola Treatment
On Oct. 14, 2024, RedHill Biopharma announced that the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA)…
Novavax’s Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Received Authorization in the EU
On Oct. 9, 2024, Novavax announced that the European Commission had granted Marketing Authorization for Novavax’s updated 2024-2025…
Oxford Researchers Received Funding to create world’s first ovarian cancer prevention vaccine
On Oct. 4, 2024, researchers from Oxford university announced they had been awarded funding from Cancer Research UK…
Biotechnology | Chemical | Disease | Oncology
Combination Chemo Helps People with Leiomyosarcoma Live Longer
On Oct. 2, 2024, results from a French clinical trial have identified what experts say should now be…
Lilly announced $4.5 billion investment in the Lilly Medicine Foundry – to drive innovation in drug production and medicines for clinical trials
On Oct. 2, 2024, Eli Lilly and Company announced a $4.5 billion investment to create the Lilly Medicine…
New approach to defibrillation may improve cardiac arrest outcomes
On Sept. 20, 2024, study results released by Oregon Health & Science University (OHSU) researchers suggested placing defibrillation…
Novavax Formula COVID-19 Vaccine Authorized and Recommended for Use in the U.S.
On Aug. 30, 2024, Novavax announced the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) had received Emergency Use…
Cannabinoid CBG reduced anxiety and stress in first human clinical trial
On Jul. 31, 2024, researchers at Washington State University (WSU) announced that the cannabigerol (CBG) effectively reduced anxiety…
CIRM approved $8 million award for plasma cell disorder therapy, $27 million to boost collaboration among California researchers
On Jul. 25, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
“LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Hong Kong
In Jul. 10, 2024, Eisai and Biogen announced that the Department of Health in Hong Kong has approved…
CIRM awarded $26 million to advance clinical research across cancer, heart conditions, and rare diseases
On Jun. 28, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
Moderna received U.S. FDA approval for RSV vaccine mRESVIA
On May 31, 2024, Moderna announced that the U.S. Food and Drug Administration (FDA) had approved mRESVIA (mRNA-1345),…
Biotechnology | Diagnostics | Infectious Disease | Medicine | Neurology | Non-Profit Research | Oncology | Therapeutics
CIRM awarded $53 million to clinical research in heart failure and cystic fibrosis, supporting 10 translational projects
On May 30, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had awarded $53 million to…
Researchers reviewed findings and clinical messages from the Women’s Health Initiative 30 years after launch
On May 1, 2024, researchers at the National Institutes of Health (NIH) announced a review in JAMA that…
Biotechnology | Diagnostics | Disease | Neurology | Non-Profit Research | Ophthalmogy | Therapeutics
CIRM awarded $31 million to fund clinical-stage research for cancers and eye disease
On Apr. 26, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had approved awarding nearly $31…
California’s Stem Cell Agency invested $25 million for discovery and preclinical research, patient support program
On Mar. 29, 2024, the California Institute for Regenerative Medicine (CIRM) announced awards that support 11 projects in…
Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer
On Mar. 13, 2024, the Fred Hutchinson Cancer Center announced that a blood test intended for screening for…
NIH launched research network to evaluate emerging cancer screening technologies
On Feb. 21, 2024, the National Institutes of Health (NIH) announced it had launched a clinical trials network…
Fred Hutch to lead new federal Cancer Screening Research Network
On Feb. 21, 2024, the Fred Hutchinson Cancer Center announced it was at the helm of a new…
Biotechnology | Diagnostics | Disease | Oncology | Vaccine | Women's Health
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
On Dec. 6, 2023, Anixa Biosciences announced updated positive results from the Phase 1 clinical trial of its…
Novartis received FDA approval for Fabhaltaﾮ (iptacopan) as the first oral monotherapy for adults with PNH
On Dec. 5, 2023, Novartis announced that the U.S. Food and Drug Administration (FDA) had approved Fabhaltaﾮ (iptacopan)…
U.S. Centers for Disease Control and Prevention Tuberculosis Trials Consortium launched new TB clinical trial
On Nov. 27, 2023, the CDCﾒs Tuberculosis Trials Consortium (TBTC) announced that it had launched an international clinical…